Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part II: Postoperative management and special considerations

  • M. Hubner*
  • , S. Kusamura
  • , L. Villeneuve
  • , A. Al-Niaimi
  • , M. Alyami
  • , K. Balonov
  • , J. Bell
  • , R. Bristow
  • , D. C. Guiral
  • , Anna Fagotti
  • , L. F. R. Falcao
  • , O. Glehen
  • , L. Lambert
  • , L. Mack
  • , T. Muenster
  • , P. Piso
  • , M. Pocard
  • , B. Rau
  • , O. Sgarbura
  • , S. P. Somashekhar
  • A. Wadhwa, A. Altman, W. Fawcett, J. Veerapong, G. Nelson
*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

Background: Enhanced recovery after surgery (ERAS) pathways have been shown to considerably reduce complications, length of stay and costs after most of surgical procedures by standardised application of best evidence-based perioperative care. The aim was to elaborate dedicated recommendations for cytoreductive surgery (CRS) ± hyperthermic intraperitoneal chemotherapy (HIPEC) in a two-part series of guidelines based on expert consensus. The present part II of the guidelines highlights postoperative management and special considerations. Methods: The core group assembled a multidisciplinary panel of 24 experts involved in peritoneal surface malignancy surgery representing the fields of general surgery (n = 12), gynaecological surgery (n = 6), and anaesthesia (n = 6). Experts systematically reviewed and summarized the available evidence on 72 identified perioperative care items, following the GRADE (grading of recommendations, assessment, development, evaluation) system. Final consensus (defined as ≥50%, or ≥70% of weak/strong recommendations combined) was reached by a standardised 2-round Delphi process, regarding the strength of recommendations. Results: Response rates were 100% for both Delphi rounds. Quality of evidence was evaluated high, moderate low and very low, for 15 (21%), 26 (36%), 29 (40%) and 2 items, respectively. Consensus was reached for 71/72(98.6%) items. Strong recommendations were defined for 37 items. No consensus could be reached regarding the preemptive use of fresh frozen plasma. Conclusion: The present ERAS recommendations for CRS ± HIPEC are based on a standardised expert consensus process providing clinicians with valuable guidance. There is an urgent need to produce high quality studies for CRS ± HIPEC and to prospectively evaluate recommendations in clinical practice.
Lingua originaleInglese
pagine (da-a)2311-2323
Numero di pagine13
RivistaEuropean Journal of Surgical Oncology
Volume46
Numero di pubblicazione12
DOI
Stato di pubblicazionePubblicato - 2020

All Science Journal Classification (ASJC) codes

  • Chirurgia
  • Oncologia

Keywords

  • Cytoreductive surgery
  • Enhanced recovery
  • Guidelines
  • HIPEC
  • Perioperative care

Fingerprint

Entra nei temi di ricerca di 'Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations — Part II: Postoperative management and special considerations'. Insieme formano una fingerprint unica.

Cita questo